UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Understanding the key features of no annual fee cards can help you maximize benefits. Discover what to prioritize for your financial needs.
18,760 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A notable fund recently reported a substantial exit in a popular beauty stock. We break down what this move could sig...
February brought a sharp setback for C3.ai investors. This article explains why shares C3.ai stock fell, what it mean...
Insider stock moves can spark questions about a company's future. This guide breaks down what viasat's chief accounti...
When a mining stock slumps, it usually signals a mix of precious metal prices, costs, and market sentiment. This piec...
As the EV race heats up in 2026, investors are weighing which rivals to buy. This guide breaks down the top contender...
Big investors are quietly using a loophole to keep buying rental properties despite bans. This article breaks down wh...
Howard Lindzon’s work with StockTwits and Social Leverage reshapes how we think about investing in communities. This ...
A viral moment where a pope’s sneakers stole the spotlight isn’t just a meme. It’s a teachable moment about money cho...
When crypto miners swing with the market, digital stock plummeting today becomes a headline. This guide breaks down t...
After years of headwinds, Target is showing early signs of life. Yet the stock price tells a story of cautious optimi...
A surprising analyst upgrade helped StubHub Holdings stock crush expectations this week. This article breaks down the...